i.Bioceuticals - Ownership and Business Overview

ChemicalsCompany

i.Bioceuticals Ownership

Who owns i.Bioceuticals?

i.Bioceuticals is owned by Groupe Berkem. It was acquired on February 16, 2023.

i.Bioceuticals Business Overview

Where is i.Bioceuticals headquartered?

i.Bioceuticals is headquartered in Orleans, Massachusetts.

What sector is i.Bioceuticals in?

i.Bioceuticals is a chemicals company.

Chemicals M&A Summary in 2023

Out of 60 sectors in the Mergr database, chemicals ranked 26 in number of deals in 2023. The largest chemicals acquisition in 2023 was Diversey - which was acquired by Solenis for $6.8B.

Subscribe to Mergr to view all 95 acquisitions of chemicals companies in 2023, including 17 acquisitions by private equity firms, and 78 by strategics.

i.Bioceuticals

i.Bioceuticals, Inc.

PO Box 2835,
Orleans, Massachusetts 02653
United States,
(508) 240-5773
www.ibioceuticals.com

i.Bioceuticals is a North American supplier of MASQUELIER’s Original OPCs and MASQUELIER’s French Pine Bark Extract. MASQUELIER’s OPCs ingredients and French Maritime Pine Bark Extract are efficacious in a broad range of physiological processes and are highly bio-active and rapidly absorbed. i.Bioceuticals is based in Orleans, Massachusetts.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for i.Bioceuticals

Chemicals Companies